The detail is informative, but these 6 new centers have no worries if delcath quickly folds

This company is not working on transparency, so I am taking today's news in a negative light

Just as inept companies carry no blame for so called investors. The odds in my view for investors in the Simpson era have never been good because of poor fundamentals. The poor fundamentals are due to challenges to get FDA approval, lack of European interest in product. Any underhanded tactics by management are not the origin of this story line.

You can never explain how anybody with due diligence should have been surprised at any time between mid-July and end of November. The company could be criticized, but certainly no more than investors in that period

you betcha, I earned the right with my topsy turvy speculations. I own it

The people most unhappy with the Simpson era of delcath stayed in after July 2017 filing threatening bankruptcy. Due diligence to avoid was CHILDS PLAY, no less, no more. If one needed more, how part one of convertible before 2017 June NO vote was very substantial icing as it was a direct cause of stock plunging more than 99 percent. Of course part 2 of convertible took it from $1.00 down to the range of 2 to 5 cents, I don't count the plunge down to $1.00 after the extraordinarily transparent coming reverse split.

So, there has never been a less justifiable complaint in stock history imo. Delcath has been bad on individual communication, but everybody who is cautious, is probably out of stock now, no biggie

Although I like the technology, it is easy to dream of this being an elephant in the animal kingdom, but alas I think probably just a mouse, one of the risks about a technology

Bankruptcy any day could be. Simpson is beating the bushes for money, who wins the next small round the part time Goddess or cold reality of nobody cares enough to fund with the risk

Do you have any idea how many people in the history of delcath that could be accused of either pumping or bashing or both?

I think it was p.t. barnum that described my birth, but my naïve attributes from birth don't make me feel alone

take the synonym "sucker", authorities are just about as likely to rob you as to prevent your being robbed, certainly delcath imo should be left in the hands of investors only, if one wants to play here, go for it

I have lost a lot of money at times in the past to complete scams, pinksheets littering the history of ihub. That is part of the institutionalized theft I have encountered in the investment world. To rely on authorities, means being a patsy.

When it comes to manipulation, I may have been manipulated a little but nothing worth speaking of. I was most manipulated by the pumping of retail particularly between 2003 and 2010, my fault, it is up to investors to resist manipulation

You either bought or held strong via rights or otherwise, after floating those 14 days were a big deal

I am a naysayer to your portrayal as you have been laying good money on the line after your advocacy of that

I rarely agree, but Jenny the Goddess if she is lucky, might can win the FDA silver medal in the end, so bragging rights will be pretty good if so but lot of folks will only see the disappointing legacy being too much

I rarely agree, but Jenny the Goddess if she is lucky, might can win the FDA silver medal in the end, so bragging rights will be pretty good if so but lot of folks will only see the disappointing legacy being too much

Noteholders manipulated to keep rights offering as healthy as possible. Now noteholders are selling I think warrants they picked up at .01, given cloudy nature who can say with certainty.

The worst part is delcath is flat broke and then some, 20 percent chance of avoiding bankruptcy as delcath has some talent on that. Only 5 percent chance $2 or better will happen in 2019, 2020, etc..

Probably not, rights holders would not be the likely users of Maxm

Legitmate? The real question is why legitimate bullish by some. They need to borrow fron turnship's analysis of last 10Q, study history, observe the little nasty financings since May, and forget about the legitimate phase 3 for now

lawsuit is imminent strikes me as the same as the old buyout is imminent

You are too optimistic. Many here don't acknowledge that there is a legitimate basis. My opinion is Simpson has a fine mind for clinical challenges, making her a Goddess by any comparison to bitter arm chair quarterbacks. The great but is over financial hell everlasting

This is a terrible company to invest in. Don't worry about FDA, lawsuits, Fbi, worry about from one month to the next future stock price. I have speculated this year on more successful financing, but it never happens

I have no idea about that or the HB lawsuit, steadfastly out of stock until and if something truly persuasive

I will again be the first to call Simpson a Goddess of the first order if FDA approval is ever achieved, maybe 20 percent chance

I believe that going below $1 is almost a lock, and very unlikely thus any Nasdaq listing. The best hope would be reaching end of phase 3 enrollment before another reverse split, in that case there may be no reverse split or bankruptcy. As usual a proper forecast is cloudy with heavy rain

Company is not a scam, it is just shaky. I can tell the difference imo. Also I thought the company was going to go bankrupt before Christmas 2017, so it may shake its way over the hill with massive dilution or not.

The rights offering was a disaster, but unbelievably it was still the best financing since 2015 for a combination of somewhat large amount of money and cheap price, but not super cheap price.

I see no reason the company should not go back to variable deal with HB if HB is willing, since management will choose any route that prevents or postpones bankruptcy.

The true kings of delcath likely sold with near 10 fold profit in the first half of 2010, and now in their leisure stop by to look and chuckle

People don't pay attention to fundamentals. Fundamentals are the threat to this company's future I believe. Bankruptcy and lawsuits have less hope for investors than erratic spikes without fundamental merit

True, it is great when poor investors are held accountable as the market intends

You can't lawsuit your way into being a good investor. You can't backstop a company from financial edge of cliff. You can get lucky with a poor company, but better to be lucky with good companies

It is only logic, nothing sweeter than the smell of success. She will probably land on her feet no matter what, but sad disappointees drive the thought process on delcath

I would call that is a half true description. Management would much prefer to avoid altogether bankruptcy with minimal dilution. Management would rather have avoided any reverse splits or doing business with HB, etc.. That remains my take.

Wrong as net $7 million means the company is as desperate as ever

There is merit to be negative here and certainly I am glad for now that I did not exercise

I claim misrepresentation as the facts show the company eats $25 million cash loss per year, so $2 million per month deals will slaughter buy and hold strategies, except for the freak runup

I believe a majority see it as manipulation, and such means only negative expectations imo. I think some folks might can sell above $2, but it is a gamble

You have to be pleased you could not if you had tried around $2 or so. In retrospect it is not wise to short when float is around $2 million dollars, but that may be expanding with speed or soon

One often gets a better outcome by not telegraphing future actions, such as when to hit a sell button